Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)
Conditions
SARS-CoV-2 · Influenza, Human · Respiratory Syncytial Virus Infections · Respiratory Distress Syndrome · Systemic Inflammatory Response Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain
Contact: Principal Investigator (José Sanz Moreno, Dr)Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain
Contact: Study coordinator (Juan Victor San Martin Lopez, Dr)Hospital Universitario Reina Sofía, Córdoba, Spain
Contact: Principal Investigator (Ángela Cano Yuste, Dr)
Study leads
David Bernal, Dr.
Principal Investigator
Hospital Universitario de Fuenlabrada
Guillermo Soria Fernández-Llamazares, Dr
Study Chair
Hospital Universitario de Fuenlabrada
José Sanz Moreno, Dr
Principal Investigator
Hospital Universitario Príncipe de Asturias
Ángela Cano Yuste, Dr
Principal Investigator
Hospital Universitario Reina Sofia de Cordoba